Altimmune
(NASDAQ:ALT)
$17.50
-0.16[-0.91%]
Last update: 2:36PM
Day High/Low16.85 - 19
52 Week High/Low3.83 - 19.04
Open / Close18.29 / -
Float / Outstanding- / 48.5M
Vol / Avg.982.9K / 1.7M
Mkt Cap849.4M
P/E-
50d Avg. Price11.47
Div / Yield-
Payout Ratio-
EPS-0.42
Total Float43.7M

Altimmune (NASDAQ:ALT), Quotes and News Summary

Altimmune (NASDAQ: ALT)

Day High/Low16.85 - 19
52 Week High/Low3.83 - 19.04
Open / Close18.29 / -
Float / Outstanding- / 48.5M
Vol / Avg.982.9K / 1.7M
Mkt Cap849.4M
P/E-
50d Avg. Price11.47
Div / Yield-
Payout Ratio-
EPS-0.42
Total Float43.7M
Sector: Health Care.Industry: Biotechnology
Altimmune Inc is a clinical-stage biopharmaceutical company focused on the development of novel peptide-based therapeutics for the treatment of obesity and liver diseases. The company's lead product candidate, pemvidutide, is a GLP-1/glucagon dual receptor agonist that is being developed for the treatment of obesity and NASH (non-alcoholic steatohepatitis). In addition, Altimmune is developing HepTcell, an immunotherapeutic designed to achieve a functional cure for chronic hepatitis B virus (HBV).

Earnings

see more
Q3 2022Est.ActualSurprise
EPS
(EXPECTED)2022-11-08
REV
Q2 2022Est.ActualSurprise
EPS-0.420
REV870.000K8.000K-862.000K

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target

Altimmune Questions & Answers

Q
How do I buy Altimmune (ALT) stock?
A

You can purchase shares of Altimmune (NASDAQ: ALT) through any online brokerage.

View our list of the best stock brokerages.

Q
Who are Altimmune's (ALT) competitors?
Q
What is the target price for Altimmune (ALT) stock?
A

The latest price target for Altimmune (NASDAQ: ALT) was reported by HC Wainwright & Co. on Wednesday, August 17, 2022. The analyst firm set a price target for 50.00 expecting ALT to rise to within 12 months (a possible 185.71% upside). 3 analyst firms have reported ratings in the last year.

Q
Current Stock Price for Altimmune (ALT)?
A

The stock price for Altimmune (NASDAQ: ALT) is $17.5 last updated Today at August 17, 2022, 6:36 PM UTC.

Q
Does Altimmune (ALT) pay a dividend?
A

There are no upcoming dividends for Altimmune.

Q
When is Altimmune (NASDAQ:ALT) reporting earnings?
A

Altimmune’s Q3 earnings are confirmed for Tuesday, November 8, 2022.

Q
Is Altimmune (ALT) going to split?
A

There is no upcoming split for Altimmune.

Q
What sector and industry does Altimmune (ALT) operate in?
A

Altimmune is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.